Join Now

Author Archives: admin

U.S. Patent Office Grants Additional Patent Protection For Exoskeleton Focal-Force Angioplasty Platform

Transit Scientific awarded increased U.S. patent protection for their novel exoskeleton focal-force angioplasty technology for use with standard off-the-shelf peripheral transluminal angioplasty (PTA) balloons. Park City, Utah USA, May 18, 2023. Transit Scientific, a Utah-based medical device company, today announced newly issued expanded U.S. patent protection for the XO exoskeleton sheath platform from the United States Patent and Trademark Office […]

Posted in BioUtah News | Comments Off on U.S. Patent Office Grants Additional Patent Protection For Exoskeleton Focal-Force Angioplasty Platform

BD Launches World’s First Spectral Cell Sorter with High-Speed Cell Imaging

FRANKLIN LAKES, N.J., May 18, 2023 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the worldwide commercial launch of a new-to-world cell sorting instrument featuring two breakthrough technologies that enable researchers to uncover more detailed information about cells that was previously invisible in traditional flow cytometry experiments. […]

Posted in BioUtah News | Comments Off on BD Launches World’s First Spectral Cell Sorter with High-Speed Cell Imaging

Michele Baptista Joins CenExel Industry powerhouse brings expertise in early phase clinical trial services to CenExel site network

Salt Lake City, Utah — CenExel announces the addition of Michele Baptista as the new Senior Director of Business Development. In this new capacity, Michele will be responsible for developing, selling, and supporting CenExel’s 18-site network for early phase clinical trials, while also identifying new business opportunities and expanding CenExel’s customer base. Michele joins CenExel from WCG IRB, where she […]

Posted in BioUtah News | Comments Off on Michele Baptista Joins CenExel Industry powerhouse brings expertise in early phase clinical trial services to CenExel site network

Biomerics Announces Merger with Precision Concepts Medical

Biomerics (“Biomerics” or the “Company”), the leading vertically integrated contract manufacturer for the interventional medical device market, announced today that it has entered into definitive agreements to merge with Precision Concepts’ Medical business (“Precision Concepts Medical”). The transaction includes the acquisition of the medical business of Precision Concepts International (“PCI”) as well as Precision Concepts […]

Posted in BioUtah News | Comments Off on Biomerics Announces Merger with Precision Concepts Medical

Sera Prognostics Announces Retirement of President and CEO Dr. Greg Critchfield and Appointment of Board Member Zhenya Lindgardt as Interim CEO

SALT LAKE CITY, May 15, 2023 /PRNewswire/ — Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced the retirement of the Company’s President and CEO, Gregory C. Critchfield, M.D., M.S. Dr. Critchfield is retiring after 12 years […]

Posted in BioUtah News | Comments Off on Sera Prognostics Announces Retirement of President and CEO Dr. Greg Critchfield and Appointment of Board Member Zhenya Lindgardt as Interim CEO

Recursion Appoints David Mauro, M.D., Ph.D., as Chief Medical Officer

SALT LAKE CITY, May 16, 2023 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has appointed David Mauro, M.D., Ph.D, as its Chief Medical Officer. Dr. Mauro will lead Recursion’s pipeline into and through clinical development, including its five programs currently in […]

Posted in BioUtah News | Comments Off on Recursion Appoints David Mauro, M.D., Ph.D., as Chief Medical Officer

Nusano and PharmaLogic Announce Collaboration to Enable Next Generation Radiotherapeutics Development

SALT LAKE CITY and BOCA RATON, Fla. – May 15, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, and PharmaLogic, a world-class contract development and manufacturing organization (CDMO) specializing in radiopharmaceuticals, today announced the two organizations will collaborate to advance the development of radiopharmaceuticals for diagnostic and therapeutic applications.   “PharmaLogic […]

Posted in BioUtah News | Comments Off on Nusano and PharmaLogic Announce Collaboration to Enable Next Generation Radiotherapeutics Development

EY Announces Marcus Gerhardt and Florian Solzbacher of Blackrock Neurotech as Entrepreneur Of The Year® 2023 Mountain West Award Finalists

SALT LAKE CITY, May 8, 2023 – Ernst & Young LLP (EY US) today announced that Marcus Gerhardt, co-founder and CEO, and Florian Solzbacher, co-founder and President, of Blackrock Neurotech were named Entrepreneur Of The Year® 2023 Mountain West Award finalists. Now in its 37th year, Entrepreneur Of The Year is one of the preeminent […]

Posted in BioUtah News | Comments Off on EY Announces Marcus Gerhardt and Florian Solzbacher of Blackrock Neurotech as Entrepreneur Of The Year® 2023 Mountain West Award Finalists

NUSANO ANNOUNCES IN-HOUSE STABLE ISOTOPE PROGRAM LED BY RENOWNED PHYSICIST SARKO CHEREKDJIAN

VALENCIA, Calif. and WEST VALLEY CITY, Utah – May 11, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced it is creating an in-house stable isotope program to enhance the company’s medical radioisotope production capabilities and decrease dependence on foreign supply chains. “Enriched, stable isotopes are foundational material for manufacturing […]

Posted in BioUtah News | Comments Off on NUSANO ANNOUNCES IN-HOUSE STABLE ISOTOPE PROGRAM LED BY RENOWNED PHYSICIST SARKO CHEREKDJIAN

Foldax, Inc. Receives Full Ownership Rights to Proprietary Polymer Patent Portfolio

SALT LAKE CITY–(BUSINESS WIRE)–Foldax® Inc. today announced that it has executed an agreement with Australia’s national science agency, CSIRO, for full ownership of a polymer technology patent family. Foldax has incorporated the polymer technology into its LifePolymer™ materials platform and has conducted testing, which indicates the materials are compatible with blood, with low adherence of […]

Posted in BioUtah News | Comments Off on Foldax, Inc. Receives Full Ownership Rights to Proprietary Polymer Patent Portfolio

Bruce Hunter named new Interim Chief Innovation and Economic Engagement Officer

By Xoel Cardenas, Sr. Communications Specialist, Office of the Vice President for Research The Partners for Innovation, Ventures, Outreach & Technology (PIVOT) Center at the University of Utah has named Bruce Hunter as the Interim Chief Innovation and Economic Engagement Officer. Hunter succeeds the role from Dr. Keith Marmer, who served as a leader for the university’s […]

Posted in BioUtah News | Comments Off on Bruce Hunter named new Interim Chief Innovation and Economic Engagement Officer

Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities

SALT LAKE CITY and TORONTO and MONTRÉAL, May 08, 2023 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has signed agreements to acquire two companies in the AI-enabled drug discovery space: Cyclica and Valence. “Recursion has pioneered the massive, parallel generation of […]

Posted in BioUtah News | Comments Off on Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities